High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Former LVMH (MC.PA, LVMUY) of North America chairman Pauline Brown assesses where consumers are still spending in the luxury retail category, noting the stronger standout names in the beauty industry.
The beauty group's repricing rests on a profit plan it controls, while the low end of its new sales guidance is no faster than the year just ended.
EL posts strong Q4 results as margin improvement, organic sales growth and broad regional gains support continued momentum into fiscal 2027.
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Management gave a positive update on the company's multi-year turnaround efforts.
Estee Lauder's (EL) turnaround continues to progress and its fiscal 2027 guidance is achievable, RBC
Este Lauder targets 3%-5% organic sales growth and a 12.7%-13.5% adjusted operating margin in fiscal 2027, with North America and Makeup in focus.
Beauty products company Estée Lauder (NYSE:EL) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 6.8% year on year to $3.64 billion. Its non-GAAP profit of $0.39 per share was 22.1% above analysts’ consensus estimates.
The in-game activation is accompanied by a campaign featuring gaming creators, livestreams and a social content series.
Shares of beauty products company Estée Lauder (NYSE:EL) jumped 17.7% in the afternoon session after It reported a cleaner quarter better than the Street expected. Revenue came in at $3.63 billion according to the company’s press release, ahead of the $3.54 billion consensus, for a 2.3% beat and 6.4% year-on-year growth. Organic sales rose 5%, also ahead of expectations, which suggests the top-line strength wasn’t just FX or one-offs. Profitability was the clearer surprise. Adjusted EPS landed a
Organic sales rose 5% in Q4, the best quarter of fiscal 2026, as the company delivered a 66% surge in diluted EPS and outlined a confident fiscal 2027 outlook.
Moby summary of The Estée Lauder Companies Inc.'s Q4 2026 earnings call
Consumer stocks were higher late Wednesday afternoon, with the State Street Consumer Staples Select
The beauty products leader's profit growth plan is working.
Estee Lauder (EL) shares rallied Wednesday after the cosmetics maker bumped up its fiscal 2027 opera
EL beats fiscal fourth-quarter estimates as sales rise 6%, fueled by Skin Care and Fragrance growth and sharply higher operating income.
On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.
Q2 retail earnings continue, Moderna sees positive Phase 3 results, and the Treasury lowers the longer-term bond rate.
Estee Lauder Companies Inc (NYSE:EL, XETRA:ELAA) shares jumped more than 15% on Wednesday after the beauty group posted fourth-quarter results that beat Wall Street estimates and raised its profit margin outlook for fiscal 2027. The company reported revenue of $3.6 billion for its fiscal...
Estee Lauder Companies (NYSE:EL) said fiscal 2026 marked a return to growth and a substantial improvement in profitability as the prestige beauty company advanced its Beauty Reimagined strategy and Profit Recovery and Growth Plan. For the full fiscal year, reported sales rose 5% and organic sales i
Although the revenue and EPS for Estee Lauder (EL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Shares of Estée Lauder advanced on Wednesday as the beauty and cosmetics giant’s better-than-expected quarterly earnings showed Wall Street its growth plan is well underway. The company announced adjusted earnings of 39 cents a share in the fiscal fourth quarter, up from 9 cents a year ago and above Wall Street’s expectation of 32 cents. Estée Lauder reported adjusted earnings of $2.51 a share for the full fiscal year, up from $1.51 last year.
Beauty products company Estée Lauder (NYSE:EL) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 6.4% year on year to $3.63 billion. Its non-GAAP profit of $0.39 per share was 23% above analysts’ consensus estimates.
The cosmetics company forecast fiscal 2027 adjusted EPS of $3.10 to $3.35, with the midpoint above analyst estimates
Estee Lauder (EL) delivered earnings and revenue surprises of +21.88% and +2.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Investing.com -- Estee Lauder shares jumped after the beauty company forecast full-year profit above Wall Street estimates, betting on sustained demand for premium fragrances and strong performance in key markets as its turnaround strategy continues to bear fruit.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
